MY ACCOUNT | NEWSLETTER |

From the night originates the light


Commenting on what happened related to investments in 2022 and what is happening is difficult. Personally, I have never experienced what we’ve gone through, but who has experienced it? 

Will things soon change, and will the calm return to a world that now seems darker, in some ways, than ever? 

A Neapolitan saying from Italy goes: “It can't get worse than the night.”

Katy Perry also sang in one of her hit songs: “After a hurricane comes a rainbow.”

Instead of starting from a concept of positivity, let's start from its exact opposite, the most negative outcome possible. I’ll analyze each of the elements that amplify the current state of negativity. With the pandemic and, for now, the energy crisis behind us, we must deal with:

  • The geopolitical transformation of the world, yet to be revealed.
  • Markets that are, for the most part, increasingly plummeting, in every segment and in every type of product.

It is in the darkest point of the night that we begin to see the light. Of course, the most pessimistic will say, “What if a nuclear war breaks out? What if Putin decides to drop his bombs on our heads?” 

History cannot be made with “what ifs.” If the pessimists’ thoughts were to come true, there would be no more history to tell. However, let us remember that we have still risen after two world wars.

So why worry about it? We should worry about what we can face, about what we can directly impact: the wrong choices that we risk making today can transform the future into a day of light or into a dark winter. 

Because if the world doesn't really end tomorrow, if we let fear guide us, it is as if the world really ends. And when the night is over, because it will pass, our very own world will remain enveloped in darkness. 

My advice? Turn off the TV, delete news apps from your phones. Get outdoors and look at life around you, take a deep breath, and rest assured that the night and darkness will pass.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Feline pemphigus foliaceus: a retrospective analysis of 57 cases

Like0
Dislike0

Clinical Case of a Transfusion-Associated Canine Mycoplasma haemocanis Infection in the Republic of Korea: A Case Report

Like0
Dislike0

Review of Nonfoodborne Zoonotic and Potentially Zoonotic Poultry Diseases

Like0
Dislike0

Solving Medical Mysteries: Dr. Philip Kass Delivers 2025 Oscar W. Schalm Lecture

Like0
Dislike0

Chewy to Acquire SmartEquine, Expanding Leadership in the Equine Health Category

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top